Jie Yang, Pingyao Xu, Guiji Zhang, Dongsheng Wang, Bo Ye, Lichun Wu: Advances and potentials in platelet-circulating tumor cell crosstalk. Am J Cancer Res 2025;15(2):407-425. (Full text, PDF)
Wenjing Qi, Shunan Zhang: SCARA5 might be one potential marker for CC and promoted Ferroptosis by FTL. Am J Cancer Res 2025;15(2):426-438. (Full text, PDF)
Liuhaonan Zeng, Yixun Tang, Xiaoling Huang, Wanmin Pei, Yongqiong Liao, Jitong Liu: Combined impact of prognostic nutritional index, fibrinogen-to-albumin ratio, and neutrophil-to-lymphocyte ratio on surgical outcomes and prognosis in hepatocellular carcinoma. Am J Cancer Res 2025;15(2):439-451. (Full text, PDF)
Linlin Guo, Yan He, Huang Xin: GDF15 promotes the resistance of epithelial ovarian cancer cells to gemcitabine via DHCR24-mediated cholesterol metabolism to elevate ABCB1 and ABCC1 levels in lipid rafts. Am J Cancer Res 2025;15(2):452-469. (Full text, PDF)
Xueyan Li, Linyu Li, Lu Zhang: Development and validation of a prediction model for myelosuppression in lung cancer patients after platinum-based doublet chemotherapy: a multifactorial analysis approach. Am J Cancer Res 2025;15(2):470-486. (Full text, PDF)
Ramona E Weber, Kiana M Schulze, Nathan J Kenney, Britton C Scheuermann, Olivia N Kunkel, Carl J Ade, Timothy I Musch, Brad J Behnke, David C Poole: Tumor bearing in untreated breast cancer decreases exercise tolerance without lowering maximal oxygen uptake in rats. Am J Cancer Res 2025;15(2):487-500. (Full text, PDF)
Xinyue Liang, Weiling Xu, Fan Zhou, Wenyang Huang, Xingcheng Yi, Yingjie Zhang, Yurong Yan, Nan Zhang, Jingxuan Wang, Xiaoxiao Sun, Rui Hu, Yufeng Zhu, Xintian Ma, Yue Sun, Maozhou Lan, Mengtuan Long, Shaji K Kumar, Yun Dai, Fengyan Jin: Dissecting the high-risk property of 1q gain/amplification in patients with newly diagnosed multiple myeloma. Am J Cancer Res 2025;15(2):501-516. (Full text, PDF)
Zilun Lei, Hao Chai, Xiaoya Liu, Yingsong Jiang: Key prognostic factors in transarterial chemoembolization combined with sorafenib treatment for hepatocellular carcinoma with portal vein tumor thrombosis. Am J Cancer Res 2025;15(2):517-532. (Full text, PDF)
William C Cho, Chi F Wong: Potential benefits of combined treatment with Hsp90 inhibitor AUY922 and cisplatin for overcoming drug resistance in nasopharyngeal carcinoma. Am J Cancer Res 2025;15(2):533-545. (Full text, PDF)
Oyeon Cho: Plasma exosomal miR-150-3p, NMT2, and PRDM1 as predictive biomarkers of acute tumor response in patients with cervical cancer undergoing chemoradiotherapy. Am J Cancer Res 2025;15(2):546-558. (Full text, PDF)
Xiaoya Hu, Mingpu Liu, Yuanli Wu, Weiying Zhou, Hongmei Wang: Cost-effectiveness analysis of trilaciclib for preventing myelosuppression in small cell lung cancer patients treated with etoposide, carboplatin, and atezolizumab. Am J Cancer Res 2025;15(2):559-572. (Full text, PDF)
Ping Yang, Shangxiang He, Linyin Fan, Ling Ye, Heng Weng: Risk factors for immunoresistance in advanced non-small cell lung cancer and the advantages of targeted therapy in improving prognosis. Am J Cancer Res 2025;15(2):573-586. (Full text, PDF)
Changlei Lv, Guoping Zhang, Bingqiang Xu, Minggang Huang, Yan Zhang, Mingqing Kou: Predictive value of CT radiomics and inflammatory markers for pulmonary adenocarcinoma spread through air spaces. Am J Cancer Res 2025;15(2):587-600. (Full text, PDF)
Margarita Santiago-Torres, Johann Lee Westmaas, Jamie S Ostroff, Kristin E Mull, Brianna M Sullivan, Joseph M Unger, Jonathan B Bricker: Overcoming challenges of recruiting cancer patients into clinical trials: insights from a randomized trial of app-based smoking cessation interventions. Am J Cancer Res 2025;15(2):601-617. (Full text, PDF, Supplementary Video)
Cherng-Chia Yang, Wan-Ming Chen, Ben-Chang Shia, Szu-Yuan Wu: Impact of long-term N-acetylcysteine use on cancer risk. Am J Cancer Res 2025;15(2):618-630. (Full text, PDF)
Juan Zhang, Ruili Wang, Xiaoxiao Duan, Juan Chen: Efficacy of a combination of O-RADS, CEUS, and CA125, in identification of ovary-adnexal malignant lesions. Am J Cancer Res 2025;15(2):631-642. (Full text, PDF)
Fatma Gharib, Mostafa Ammar, Ahmed S Elhamshary, Mohamed Sheta, Wael Mansour, Asma M Elkady: Comparative study between single modality radiotherapy and concurrent chemoradiation for selected patients with early-stage laryngeal cancer. Am J Cancer Res 2025;15(2):643-651. (Full text, PDF)
Yanan Jing, Chan Liu, Lijun Wang, Xiaoxi Liu, Lei Wang: Association between psychological resilience and symptom burden in postoperative patients with brain gliomas and its influencing factors. Am J Cancer Res 2025;15(2):652-660. (Full text, PDF)
Jialian Feng, Yatian Liu, Jianguo He, Xiao Jiao: Pediatric nasal septum pleomorphic adenoma: a case report. Am J Cancer Res 2025;15(2):661-664. (Full text, PDF)
Junjie Wang, Qin Zhang, Liwen Chen: Microporous annealed particle hydrogels in cell culture, tissue regeneration, and emerging application in cancer immunotherapy. Am J Cancer Res 2025;15(2):665-683. (Full text, PDF)
Joy Okoro, Raviteja Bulusu, Esther Frimpong, Xue Zhu, Sherise Rogers, Edward Agyare: A novel gemcitabine analog as a potential anticancer agent: synthesis and in-vitro evaluation against pancreatic cancer. Am J Cancer Res 2025;15(2):684-704. (Full text, PDF)
Esther Frimpong, Eugene Annor, Raviteja Bulusu, Joy Okoro, Gebre-Egziabher Kiros, Renee Reams, Edward Agyare: Sociodemographic characteristics associated with pancreatic cancer incidence and mortality among Blacks in the United States: a SEER-based study. Am J Cancer Res 2025;15(2):705-722. (Full text, PDF)
Nai-Wen Kang, Kuei-Li Lin, Kai-Yuan Lin, Yin-Hsun Feng, Chung-Han Ho, Yi-Chen Chen, Ching-Chieh Yang: Radiotherapy can significantly improve survival outcomes in patients with muscle-invasive bladder cancer who are unsuitable for cystectomy or chemoradiotherapy. Am J Cancer Res 2025;15(2):723-736. (Full text, PDF)
Chih-Jan Ko, Hung-Yu Lin, Pei-Min Hsieh, Wen-Lung Wang, Szu-Ying Chen, Li-Wei Chou, Yaw-Sen Chen, Yu-Wei Huang, Wen-Chao Ho, Chih-Wen Lin: Association of concomitant MASLD and hepatitis B virus with clinical prognosis in hepatocellular carcinoma after curative resection. Am J Cancer Res 2025;15(2):737-748. (Full text, PDF)
Katie Moreland, Bethany Fuhrman, Kayla Webb, Melanie Margraf, Jessica Wernke, Christine Vollmer, Alison Kastl, Michelle Marcum, Jennifer Leddon, Amanda Jackson, Emily Curran, Shesh Rai, Trisha Wise-Draper, Davendra Sohal: Early-phase clinical trials in the pandemic era: a four-year experience from an academic cancer center. Am J Cancer Res 2025;15(2):749-753. (Full text, PDF)
Kalappanaickenpatty Suriaprakasam Manojee, Athiappan Rajiv Kannan: Patho-Net: enhancing breast cancer classification using deep learning and explainable artificial intelligence. Am J Cancer Res 2025;15(2):754-768. (Full text, PDF)
Luwei Wei, Guowei Chen, Huiying Liang, Li Li: Random survival forest model in patients with epithelial ovarian cancer: a study based on SEER database and single center data. Am J Cancer Res 2025;15(2):769-780. (Full text, PDF)
Yujie Huang, Guang Han: Predictive nomogram for risk of pulmonary infection in lung cancer patients undergoing radiochemotherapy: development and performance evaluation. Am J Cancer Res 2025;15(2):781-796. (Full text, PDF)
Ning Dong, Sirong Wei, Lei Zheng, Delong Huang, Guowei Zhang, Yunxin Li, Hu Zhang, Aijie Wang, Ranran Huang, Xinyao Zhao, Peng Liang: Nomogram integrating clinical-radiological and radiomics features for differentiating invasive from non-invasive pulmonary adenocarcinomas presenting as ground-glass nodules. Am J Cancer Res 2025;15(2):797-810. (Full text, PDF)
Yuan-Hung Kuo, Yen-Hao Chen, Ming-Chao Tsai, Sheng-Nan Lu, Tsung-Hui Hu, Chao-Hung Hung, Chien-Hung Chen, Jing-Houng Wang: Comparing health insurance-reimbursed lenvatinib and self-paid atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma. Am J Cancer Res 2025;15(2):811-823. (Full text, PDF)
Nan Duan, Zhihui Li, Zhiyan Li, Lu Pang, Jialin Du, Le Chang, Haiming Huang, Haixia Li: Evaluation of a tumor marker gastrin-releasing peptide precursor in the patients with kidney injuries. Am J Cancer Res 2025;15(2):824-832. (Full text, PDF)
Parvin Ataie-Kachoie, Krishna Pillai, Samina Badar, Javed Akhter, David Lawson Morris: Monepantel considerably enhances the therapeutic potentials of PEGylated liposomal doxorubicin and gemcitabine in ovarian cancer: in vitro and in vivo studies: Am J Cancer Res. 2018; 8(10): 2064-2075. Am J Cancer Res 2025;15(2):833-834. (Full text, PDF)
